🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers.

Recruitingn/aAges 18 Years - anyAllRoyal Cornwall Hospitals Trust
NCT06849284 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To perform a post-market study of the performance of the Idylla™ ThyroidPrint® Assay using clinical samples in predicting the nature of indeterminate thyroid nodules (ITNs) across multiple centers.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Thyroid nodule ≥1.0 cm * With indeterminate cytology * Surgery due to be performed Exclusion Criteria: * Specimens which fail to meet the inclusion criteria. * FNA fixed in formalin or transferred in alcohol-based collection buffers which is not according to the protocol instructions. * RNA extracts. * Patients with ultrasound evidence of malignant cervical adenopathy
💊

What it tests

  • Not listed
📍

Where

1 site
Royal Cornwall Hospital
Truro, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy